Evidence map›Paper›PMID 28352670›Full record

ArticleOpen medicine (Warsaw, Poland)2015

Integration of human papillomavirus type 16 in cervical cancer cells.

Zivile Gudleviciene, Daiva Kanopiene, Ausra Stumbryte, Raminta Bausyte, Edgaras Kirvelaitis, Vaida Simanaviciene, Aurelija Zvirbliene

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open medicine (Warsaw, Poland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zivile GudlevicieneInstitute of Oncology, Vilnius University, Santariskiu str. 1, LT-08660 Vilnius, Lithuania.
Daiva KanopieneInstitute of Oncology, Vilnius University, Santariskiu str. 1, LT-08660 Vilnius, Lithuania.
Ausra StumbryteInstitute of Oncology, Vilnius University, Santariskiu str. 1, LT-08660 Vilnius, Lithuania. Vilnius University, Universiteto str. 3, LT-01513 Vilnius, Lithuania.
Raminta BausyteVilnius University, Universiteto str. 3, LT-01513 Vilnius, Lithuania.
Edgaras KirvelaitisVilnius University, Universiteto str. 3, LT-01513 Vilnius, Lithuania.
Vaida SimanavicieneInstitute of Biotechnology of Vilnius University, V.A.Graiciuno 8, LT-02241 Vilnius, Lithuania.
Aurelija ZvirblieneInstitute of Biotechnology of Vilnius University, V.A.Graiciuno 8, LT-02241 Vilnius, Lithuania.
Vilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer remains an important cause of women morbidity and mortality. The progression of cervical pathology correlates with the HPV integration into the host genome. However, the data on the viral integration status in cervical dysplasias are controversial. The aim of the current study was to evaluate the status of HPV integration in two types of cervical pathology - invasive and non invasive cervical cancer (e.g. carcinoma

Indexed as

carcinoma in situcervical cancerHPV16 E2 deletionHPV16 integration

Identifiers

PMID28352670
PMCPMC5152952
OpenAlexW1986085145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.